이 기사의 번역을 준비하고 있습니다. 그동안 영어 원문을 임시로 표시합니다.
비즈니스 · 1999. 2. 26.1 분 읽기
Agency Information Collection Activities; Announcement of OMB Approval; Regulations Requiring Manufacturers to Assess the Safety and Effectiveness of New Drugs and Biological Products in Pediatric Patients
로컬 자동 번역 · 원본 출처 언어
요약
The Food and Drug Administration (FDA) is announcing that a collection of information entitled ``Regulations Requiring Manufacturers to Asses the Safety and Effectiveness of New Drugs and Biological Products in Pediatric Patients'' has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.
원본 출처 언어: Federal Register — Food and Drug Administration원문 발표 열기 →